Circulating Biomarkers in Hypertrophic Cardiomyopathy

Circulating Biomarkers in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy is the most common genetic heart disease. Biomarkers, molecules measurable in the blood, could inform the clinician by aiding in diagnosis, directing treatment, and predicting outcomes. We present an updated review of circulating biomarkers in hypertrophic cardiomyopathy...

Full description

Bibliographic Details
Main Authors: Eldon L. Matthia, Michael L. Setteducato, Mohammed Elzeneini, Nicholas Vernace, Michael Salerno, Christopher M. Kramer, Ellen C. Keeley
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
biomarker
cardiac imaging
hypertrophic cardiomyopathy
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.027618

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.027618

Similar Items